Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

Impact · against what's priced in

The news provides no material catalyst for Moderna or Revolution Medicines, as the existence of upcoming catalysts is already reflected in the current valuations. The market is currently reacting to broader biotech sector volatility rather than company-specific fundamentals.

MRNA+0.00: Already priced in
The price assumes: the validation of the mRNA oncology platform
The mention of upcoming catalysts to sustain gains is already baked into the current price, which pays for the success of the oncology platform and its melanoma trial results.
What MRNA's price assumes · Sep 11

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

biotech▲11%
pharmaceuticals
MRNA
RVTX
catalysts
moderna
revolution medicines

Top 1 mover · tap to explore

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

How each ticker is affected

Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

How each ticker is affected

Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Track these names every morning.

enGene Highlights Surfactant-Enhanced Bladder Cancer Therapy Data and 2027 Update Path

Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026 for a Leadership Role

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

How each ticker is affected

Next reads from the same story arc

Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather

How each ticker is affected

Next reads from the same story arc

Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady

Track these names every morning.

enGene Highlights Surfactant-Enhanced Bladder Cancer Therapy Data and 2027 Update Path

Kaplan Fox Encourages Ardelyx, Inc. (ARDX) Investors to Contact the Firm Before the Deadline on November 16, 2026 for a Leadership Role

Amgen (AMGN) Exceeds Market Returns: Some Facts to Consider

Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets